Skip to main content

Table 4 Genes sorted by SVM weight, schizophrenia versus control

From: Combining gene expression, demographic and clinical data in modeling disease: a case study of bipolar disorder and schizophrenia

Expression data only

Demographic, clinical, and expression data

All subjects

All subjects

SVM-weight

p-value

q-value

ID

GenBank

Symbol

SVM-weight

p-value

q-value

ID

GenBank

Symbol

-6.70E-02

1.13E-03

2.46E-01

201137_s_at

NM_002121

HLA-DPB1

1.06E-01

1.39E-10

3.11E-06

Drug use

  

5.99E-02

4.71E-02

1.00E+00

214877_at

BE794663

CDKAL1

6.74E-02

2.88E-09

3.21E-05

Alcohol use

  

-5.62E-02

1.19E-01

1.00E+00

218948_at

AL136679

QRSL1

5.16E-02

4.71E-02

1.00E+00

214877_at

BE794663

CDKAL1

-5.50E-02

5.31E-05

4.79E-02

203851_at

NM_002178

IGFBP6

-5.07E-02

5.31E-05

4.30E-02

203851_at

NM_002178

IGFBP6

-5.29E-02

6.22E-03

5.62E-01

204545_at

NM_000287

PEX6

-5.05E-02

6.22E-03

5.51E-01

204545_at

NM_000287

PEX6

5.21E-02

1.17E-01

1.00E+00

202944_at

NM_000262

NAGA

-4.84E-02

1.19E-01

1.00E+00

218948_at

AL136679

QRSL1

-4.83E-02

7.19E-02

1.00E+00

201123_s_at

NM_001970

EIF5A

4.60E-02

1.17E-01

1.00E+00

202944_at

NM_000262

NAGA

4.79E-02

7.06E-02

1.00E+00

210075_at

AF151074

2-Mar

4.57E-02

9.84E-02

1.00E+00

206785_s_at

NM_002260

KLRC2/1

4.76E-02

7.70E-02

1.00E+00

204418_x_at

NM_000848

GSTM2

-4.56E-02

1.13E-03

2.35E-01

201137_s_at

NM_002121

HLA-DPB1

4.76E-02

6.82E-02

1.00E+00

204550_x_at

NM_000561

GSTM1

-4.55E-02

5.69E-02

1.00E+00

218055_s_at

NM_018268

WDR41

-4.64E-02

9.14E-02

1.00E+00

218051_s_at

NM_022908

NT5DC2

4.51E-02

7.06E-02

1.00E+00

210075_at

AF151074

2-Mar

-4.56E-02

6.35E-02

1.00E+00

218002_s_at

NM_004887

CXCL14

-4.38E-02

5.28E-02

1.00E+00

219592_at

NM_024596

MCPH1

4.52E-02

9.84E-02

1.00E+00

206785_s_at

NM_002260

KLRC2/1

-4.31E-02

4.12E-02

1.00E+00

205145_s_at

NM_002477

MYL5

-4.48E-02

9.45E-02

1.00E+00

204295_at

NM_003172

SURF1

-4.23E-02

2.78E-02

1.00E+00

206108_s_at

NM_006275

SFRS6

-4.47E-02

2.78E-02

1.00E+00

206108_s_at

NM_006275

SFRS6

4.15E-02

6.82E-02

1.00E+00

204550_x_at

NM_000561

GSTM1

4.45E-02

3.91E-03

4.65E-01

212854_x_at

AB051480

NBPF10

4.14E-02

3.91E-03

4.54E-01

212854_x_at

AB051480

NBPF10

-4.37E-02

5.28E-02

1.00E+00

219592_at

NM_024596

MCPH1

-4.04E-02

6.35E-02

1.00E+00

218002_s_at

NM_004887

CXCL14

4.34E-02

1.10E-01

1.00E+00

201141_at

NM_002510

GPNMB

-3.98E-02

7.19E-02

1.00E+00

201123_s_at

NM_001970

EIF5A

4.32E-02

2.48E-02

1.00E+00

215823_x_at

U64661

LOC341315

3.96E-02

7.62E-06

1.13E-02

Smoking at TOD

  

4.28E-02

4.33E-02

1.00E+00

221752_at

AL041728

SSH1

3.93E-02

2.48E-02

9.94E-01

215823_x_at

U64661

LOC341315

Male subjects

Male subjects

-5.90E-02

1.59E-04

4.87E-02

201137_s_at

NM_002121

HLA-DPB1

7.25E-02

2.42E-10

5.40E-06

Drug use

  

-5.81E-02

8.14E-02

9.87E-01

218948_at

AL136679

QRSL1

6.57E-02

1.79E-09

1.33E-05

Alcohol use

  

-5.36E-02

2.46E-02

6.09E-01

218055_s_at

NM_018268

WDR41

-6.16E-02

3.87E-04

8.24E-02

HSV 1 OD Z-score

  

4.73E-02

7.55E-03

3.68E-01

215009_s_at

U92014

SEC31A

-5.44E-02

2.46E-02

6.04E-01

218055_s_at

NM_018268

WDR41

3.97E-02

7.06E-02

9.39E-01

209823_x_at

M17955

HLA-DQB1

-4.98E-02

8.14E-02

9.84E-01

218948_at

AL136679

QRSL1

3.97E-02

3.96E-03

2.69E-01

220313_at

NM_022049

GPR88

4.71E-02

7.55E-03

3.64E-01

215009_s_at

U92014

SEC31A

3.90E-02

2.96E-02

6.65E-01

204550_x_at

NM_000561

GSTM1

-4.11E-02

1.59E-04

4.68E-02

201137_s_at

NM_002121

HLA-DPB1

3.64E-02

6.72E-02

9.24E-01

214877_at

BE794663

CDKAL1

4.03E-02

4.45E-04

8.62E-02

Smoking at TOD

  

-3.63E-02

9.60E-05

3.77E-02

203851_at

NM_002178

IGFBP6

3.97E-02

3.96E-03

2.64E-01

220313_at

NM_022049

GPR88

-3.59E-02

8.41E-02

9.94E-01

221875_x_at

AW514210

HLA-F

3.67E-02

5.43E-02

8.51E-01

203554_x_at

NM_004219

PTTG1

3.58E-02

2.52E-02

6.15E-01

201141_at

NM_002510

GPNMB

-3.43E-02

8.71E-03

3.84E-01

204670_x_at

NM_002125

HLA-DRB1

-3.58E-02

1.57E-02

4.94E-01

203031_s_at

NM_000375

UROS

-3.35E-02

8.41E-02

9.90E-01

221875_x_at

AW514210

HLA-F

-3.56E-02

1.26E-02

4.60E-01

204295_at

NM_003172

SURF1

-3.32E-02

1.57E-02

4.90E-01

203031_s_at

NM_000375

UROS

3.56E-02

5.43E-02

8.55E-01

203554_x_at

NM_004219

PTTG1

-3.31E-02

9.60E-05

3.58E-02

203851_at

NM_002178

IGFBP6

3.55E-02

4.40E-02

7.84E-01

206339_at

NM_004291

CARTPT

3.26E-02

4.40E-02

7.80E-01

206339_at

NM_004291

CARTPT

-3.52E-02

9.35E-02

1.00E+00

208729_x_at

D83043

HLA-B

3.25E-02

7.06E-02

9.36E-01

209823_x_at

M17955

HLA-DQB1

-3.50E-02

8.71E-03

3.88E-01

204670_x_at

NM_002125

HLA-DRB1

-3.24E-02

9.35E-02

1.00E+00

208729_x_at

D83043

HLA-B

3.48E-02

6.76E-02

9.25E-01

221752_at

AL041728

SSH1

3.21E-02

6.76E-02

9.21E-01

221752_at

AL041728

SSH1

-3.46E-02

7.98E-02

9.82E-01

203374_s_at

AW612376

TPP2

3.16E-02

6.18E-02

8.93E-01

204570_at

NM_001864

COX7A1

3.38E-02

6.18E-02

8.97E-01

204570_at

NM_001864

COX7A1

3.09E-02

2.96E-02

6.61E-01

204550_x_at

NM_000561

GSTM1

Female subjects

Female subjects

2.54E-02

1.85E-03

1.00E+00

219044_at

NM_018271

THNSL2

3.49E-02

2.07E-02

1.00E+00

Left brain

  

-2.18E-02

1.71E-02

1.00E+00

208691_at

BC001188

TFRC

2.44E-02

1.85E-03

1.00E+00

219044_at

NM_018271

THNSL2

-2.12E-02

2.36E-01

1.00E+00

202747_s_at

NM_004867

ITM2A

-2.08E-02

1.71E-02

1.00E+00

208691_at

BC001188

TFRC

-2.04E-02

1.75E-01

1.00E+00

200606_at

NM_004415

DSP

2.07E-02

5.93E-04

1.00E+00

Age

  

-2.03E-02

2.05E-01

1.00E+00

204305_at

NM_005932

MIPEP

-2.03E-02

2.36E-01

1.00E+00

202747_s_at

NM_004867

ITM2A

-2.01E-02

6.29E-02

1.00E+00

207332_s_at

NM_003234

TFRC

-1.99E-02

1.75E-01

1.00E+00

200606_at

NM_004415

DSP

-1.92E-02

5.61E-02

1.00E+00

202746_at

AL021786

ITM2A

-1.96E-02

2.05E-01

1.00E+00

204305_at

NM_005932

MIPEP

-1.86E-02

2.60E-02

1.00E+00

220576_at

NM_024989

PGAP1

-1.91E-02

6.29E-02

1.00E+00

207332_s_at

NM_003234

TFRC

1.79E-02

1.69E-01

1.00E+00

209619_at

K01144

CD74

-1.82E-02

5.61E-02

1.00E+00

202746_at

AL021786

ITM2A

1.77E-02

1.23E-01

1.00E+00

220954_s_at

NM_013440

PILRB

-1.78E-02

2.60E-02

1.00E+00

220576_at

NM_024989

PGAP1

-1.75E-02

1.35E-03

1.00E+00

201865_x_at

AI432196

NR3C1

1.76E-02

1.23E-01

1.00E+00

220954_s_at

NM_013440

PILRB

-1.73E-02

9.17E-02

1.00E+00

209735_at

AF098951

ABCG2

1.69E-02

1.69E-01

1.00E+00

209619_at

K01144

CD74

-1.71E-02

2.97E-01

1.00E+00

209314_s_at

AK024258

HBS1L

1.68E-02

8.54E-02

1.00E+00

Drug use

  

-1.71E-02

5.99E-02

1.00E+00

209267_s_at

AB040120

SLC39A8

-1.66E-02

1.35E-03

1.00E+00

201865_x_at

AI432196

NR3C1

-1.70E-02

2.88E-01

1.00E+00

218051_s_at

NM_022908

NT5DC2

-1.65E-02

9.17E-02

1.00E+00

209735_at

AF098951

ABCG2

-1.66E-02

1.83E-01

1.00E+00

213791_at

NM_006211

PENK

-1.62E-02

5.99E-02

1.00E+00

209267_s_at

AB040120

SLC39A8

-1.66E-02

1.75E-01

1.00E+00

203697_at

U91903

FRZB

-1.61E-02

1.75E-01

1.00E+00

203697_at

U91903

FRZB

-1.63E-02

9.02E-02

1.00E+00

202688_at

NM_003810

TNFSF10

-1.61E-02

2.88E-01

1.00E+00

218051_s_at

NM_022908

NT5DC2

-1.62E-02

2.61E-01

1.00E+00

217757_at

NM_000014

A2M

-1.55E-02

1.83E-01

1.00E+00

213791_at

NM_006211

PENK

-1.60E-02

6.61E-03

1.00E+00

211671_s_at

U01351

NR3C1

-1.55E-02

3.39E-01

1.00E+00

222274_at

AW975050

FLJ31568